Lung fluid clues could help predict sarcoma spread

NCT ID NCT06815666

Recruiting now Knowledge-focused Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at fluid from the lungs of 70 people with soft-tissue sarcoma that has spread to the lungs. Researchers will check for specific inflammatory markers to see if they can predict how the disease will progress. The goal is to better understand the disease, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to predict how soft-tissue sarcoma will progress in the lungs, helping doctors tailor monitoring and treatment.
What could go wrong: This is a small, early-phase study focused on observation, not treatment. The biomarkers may not reliably predict outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOALVEOLAR LAVAGE (BAL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHOALVEOLAR LAVAGE (BAL) BRONCHOALVEOLAR LAVAGE FLUID SOFT TISSUE SARCOMA (STS)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
RECRUITING

Toronto, Ontario, M5G 2M9, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.